Biosimilar Interchangeability Switching Studies May Use Foreign Comparators US FDA Says
Biosimilar Interchangeability Switching Studies May Use Foreign Comparators, US FDA Says
17:36 EDT 12 May 2019 |
SCRIP
But scientific bridging required for non-US reference products might be more extensive than in other contexts, agency cautions; easing of...
More From BioPortfolio on "Biosimilar Interchangeability Switching Studies May Use Foreign Comparators, US FDA Says"